Monday | Health Care Renewal
This is just in case anyone thought this was only an American pheonomenon. As reported by the Independent .
Reprieve as cancer drug funded
A Powys man suffering from cancer has been told he will now receive a potentially life-enhancing drug after his local health board agreed to fund it.
WANG Wenwen, an 8-year-old girl from Jiangsu Province who was abandoned at birth, is receiving treatment for kidney cancer at Shanghai hospitals, thanks to her adoptive parents.
Drug Sorafenib Improves Kidney Cancer Outcomes
People with kidney cancer, regardless of age, seem to benefit from and tolerate sorafenib drug therapy equally well, a new study says.
Kidney cancer mortality in Spain: geographic patterns and possible hypotheses
Since the second half of the 1990s, kidney cancer mortality has tended to stabilize and decline in many European countries, due to the decrease in the prevalence of smokers.
Accrington building firm boss dies, 44
A 44-year-old Accrington building firm boss who a fought cancer to his last breatha has died aged 44.
Wyeth Pharmaceuticals promotes new drug for renal cell cancer treatment
A new target therapy drug, which can effectively extend the lives of people in the last stages of renal cell cancer by about 11 months, is now on the market, doctors said in Taipei yesterday.
Family anger as NHS refuses cancer drug funding
A FAMILY has spoken of their anger after the NHS has refused funding for a life-prolonging cancer drug.
Breast Cancer Patient Can No Longer Afford To Save Her Own Life
Main Category: Health Insurance / Medical Insurance Article Date: 05 Oct 2008 - 0:00 PDT "We had major medical health insurance when I was diagnosed with breast cancer in 1987," recalls Leslie Elder of West ...
Lonedell Family Fights Together After Cancer Diagnosis
Six weeks ago, life was normal for the Hudson family of Lonedell. Julie Brinkmann Hudson had three healthy boys, two of whom were getting ready for the start of school.
When a patient is treated for kidney cancer, surgeons remove the affected kidney as part of treatment.
Idera Pharmaceuticals, Inc. Drug IMO-2055 Disappoints as Kidney Cancer Treatment
Idera Pharmaceuticals, Inc. , today announced preliminary data from the first part of a Phase 2 clinical study conducted by the Company of IMO-2055 monotherapy in patients with metastatic or recurrent clear ...
Idera drug disappoints as kidney cancer treatment
Idera Pharmaceuticals Inc. is reporting disappointing preliminary data from a midstage human clinical trial for a form of kidney cancer The Cambridge, Mass-based company said on Wednesday that the test of ...
Research Suggests Doctors Should Consider Kidney-Sparing Surgery
A study of almost 1,500 kidney cancer patients treated at Memorial Sloan Kettering Cancer Center suggests that surgery to spare as much kidney tissue as possible may improve overall survival in patients who ...
FDA Grants Permission For Export of Antigenics' Oncophage to Russia
NEW YORK, Sept. 29, 2008-- --Antigenics Inc. today announced that the U.S. Food and Drug Administration has granted the necessary permission to allow for the export of Oncophage to Russia.
Angiogenesis and Angiogenesis Inhibitors to Treat Cancer
Angiogenesis is the formation of new blood vessels. This process is normal in the growth and development of children, but happens less often in adults.
Hounslow cancer lottery worst in UK
Geoff Martin, of campaign group London Health Emergency, said: "These decisions are driven purely by money but you can't put a price on life-saving treatments.
Cancer drug protest by ex-mayor
Christopher Lewis says a 12-month treatment for him would cost 22,000. A former town mayor who has terminal cancer has protested at the Senedd in Cardiff Bay to call for the drug Sutent to be available to all ...
Global Insight's Analysis Of Nice's Rejection Of Cancer Drug Erbitux For NHS Use, UK
Global Insight's Senior Analyst/Oncology Gustav Ando's note on NICE's rejection of cancer drug Erbitux for NHS use.
TWO cancer charities are hitting out at NHS guidelines which mean people with terminal kidney cancer cannot get funding for a drug which would prolong their lives.